Juvenescence investing $43.2 million in AgeX

Juvenescence will purchase, in a single transaction, 14.4 million shares of AgeX Therapeutics from BioTime for $43.2 million. 50% of the purchase price will be paid to BioTime in cash and the...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]